global health financing
Upload: institute-for-health-metrics-and-evaluation-university-of-washington
Post on 14-Apr-2017
454 views
TRANSCRIPT
![Page 1: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/1.jpg)
Global Health Financing“Follow the money” in order to better understand the framework for global health governance
Timothy K. Mackey, MAS, PhDFundamentals of Global Health
Summer 2016
![Page 2: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/2.jpg)
$35.9 billion
36.4 billion in DAH (2015)
1.5 trillion DOD project(400bil over budget)
![Page 3: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/3.jpg)
Fast Facts:
US accounts for largest source of DAH ($13.1 billion)
$2.9 billion v. $5.4 billion?
96.6% increase
Increase in funding for “other” infectious diseases (including 1.1b for Ebola)
from 2013
![Page 4: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/4.jpg)
GLOBAL HEALTH FINANCINGMACRO TRENDS (1990-2014)
1990 -2000
2000 -
2010
2011 -
2013 2015 Future
Marked by minor but
stable increases in DAH. 5.4% annualized
growth.
Rapid growth
following launch of
MDGs. Peak of 11.3% annual
growth rate.
Slowing in growth due
to global fiscal crisis. 2013-2014
DAH dropped
1.6%.
$36.4 billion less than
overall high in of 38bil in
2013. Change in funding flows.
Plateauing of DAH? Are the new
SDGs set to evolve DAH
disbursements?
![Page 5: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/5.jpg)
![Page 6: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/6.jpg)
![Page 7: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/7.jpg)
![Page 8: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/8.jpg)
McCoy et al. (2009)
• Older article from 2009; most analysis on DAC OECD donors
• Data sources comprised of secondary data from published literature; annual reports of actors; and unpublished data (grants etc.)
• Maps and differentiates the source, management, and spending of global health funds
• Fragmentation of funding, complicated and inadequately tracked
• Proliferation of actors with impact not well known
![Page 9: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/9.jpg)
Funding Instruments
![Page 10: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/10.jpg)
Funding Instruments
![Page 11: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/11.jpg)
![Page 12: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/12.jpg)
![Page 13: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/13.jpg)
Szlezak et al. (2010)
• PLoS Med, Harvard, funded, commissioned as part of 4 series on Global Health financing
• (1) essential characteristics of functioning national health system; (2) case study of Malaria and changes in partnerships, research, and delivery; (3) further research on 3 primary questions of project.
• Improvement of coordination necessary to avoid waste, inefficiency and turf wars
• Sustainable financing and equitable resource sharing
• Ensuring sufficient long-term investment and creating mechanisms for M&E
• Role and effectiveness?
![Page 14: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/14.jpg)
![Page 15: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/15.jpg)
Funding Instruments - IHME
“SOURCE”
“CHANNEL”
“RECIPIENT”
![Page 16: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/16.jpg)
Sridhar (2012)
• Multi-Bi Financing? Essentially earmarked funds provided to multilateral agencies (vs. multilateral and bilateral)
• Highlights increases in WHO voluntary contributions and World Bank’s increases in its trust fund portfolio
• Multi-bi allows funders to realign objectives of multilaterals with their own and side step governance structures and engage in “performance-based” financing
• Priority setting behind the scenes? Autonomy of multilaterals?
![Page 17: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/17.jpg)
![Page 18: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/18.jpg)
Beginning 1980s U.S. withholds or threatens to withhold arrears, specific programs targeted. 1985 Kassenbaum-Solomon Amendment made withholding contingent upon U.N. reform.
U.S. Congress continues withholdings, U.N. does not recognize reduction in U.S. assessment. By 1998 U.S. arrears total $1.29 billion. U.N. suffers, with U.S. representing 2/3rds of total arrears.
By 1998, U.S. risks losing vote in U.N. General Assembly due to build up of arrears. In response, U.S. Congress enacts Helms-Biden Act to authorize payments.
Progression to Helms-Biden LegislationHistory of U.S. – U.N. Arrears
1990s
1980s
Helms-Biden
![Page 19: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/19.jpg)
Conflict and CooperationHistory of U.S. – U.N. Relationship
• Staged Payments: Authorized staged payments of arrears to U.N.
• Reforms: Required U.N. reforms including zero-growth restriction on U.N. budget and reductions in U.S. assessments
• Negotiation: U.N. and other member states eventually agree to phased reductions in U.S. assessments
The late Richard Holbrooke, then ambassador to the U.N., was instrumental in negotiating the Helms-Biden Act provisions
Key Facts:-U.S. historically pays highest U.N. assessments-Proportionate share lower than poorer countries-29 countries agreed to higher assessments -U.N. suffered severe shortages and had to borrow money for operations
![Page 20: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/20.jpg)
![Page 21: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/21.jpg)
![Page 22: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/22.jpg)
![Page 23: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/23.jpg)
![Page 24: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/24.jpg)
![Page 25: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/25.jpg)
![Page 26: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/26.jpg)
![Page 27: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/27.jpg)
![Page 28: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/28.jpg)
![Page 29: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/29.jpg)
![Page 30: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/30.jpg)
![Page 31: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/31.jpg)
![Page 32: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/32.jpg)
![Page 33: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/33.jpg)
![Page 34: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/34.jpg)
![Page 35: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/35.jpg)
![Page 36: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/36.jpg)
![Page 37: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/37.jpg)
![Page 38: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/38.jpg)
![Page 39: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/39.jpg)
![Page 40: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/40.jpg)
![Page 41: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/41.jpg)
![Page 42: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/42.jpg)
![Page 43: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/43.jpg)
World Health Organization
![Page 44: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/44.jpg)
NEXT: In-class workshop: Global Health
Financing?
![Page 45: Global Health Financing](https://reader035.vdocuments.net/reader035/viewer/2022081520/58f0d3b81a28ab6c2e8b4619/html5/thumbnails/45.jpg)
In-class Workshop (if time permits): Groups of 4
1) Pick a Global Health Actor: Pick a global health actor to explore. It can be a country, a multilateral, a bilateral agency, an NGO/private foundation, or a private sector actor.
2) Identify Key Characteristics: Search the internet to identify the following key characteristics:
a) Type of actor: What type of actor is this (state government, UN agency, bilateral, public-private partnership etc.)?
b) What type of instrument is it? : Is it a source, channel, recipient, or some combination thereof?
c) Organization budget: Google search to try to find out what the organization’s overall budget is. If information is available, check to see what it is generally spent on (diseases, health projects, etc.)
3) Student Presentation: Report findings and tell us in general how influential you think this organization is in the context of the entire global health system.